ARROW ALEXANDER K. (Chief Financial Officer) purchased 25.8% of their position (31K shares) of PROTAGENIC THERAPEUTICS, INC.\NEW on the open market
Open‑market purchase worth $22.1K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/18/2022ACC: 0001493152-22-014338
Officer· Chief Financial Officer
Since Mar 2019
+31K
Net shares
Net buyer
$22.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
31K acquired
Non-Derivative Transactions2
PTIX Common Stock
Direct
Shares
+23K
Price / share
$0.71
Trade value
$16.33K
% of position
19.1%
5/17/2022
120.26K→143.26K
PTIX Common Stock
Direct
Shares
+8K
Price / share
$0.72
Trade value
$5.76K
% of position
5.6%
5/18/2022
143.26K→151.26K
Total
Net shares
+31K
Net value
$22.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| PTIX Common Stock Direct | 5/17/2022 | P · Purchase | +23K | $0.71 | $16.33K | 19.1% | 120.26K | 143.26K |
| PTIX Common Stock Direct | 5/18/2022 | P · Purchase | +8K | $0.72 | $5.76K | 5.6% | 143.26K | 151.26K |
| Total | +31K | $22.09K | ||||||
Derivative Transactions0
No derivative transactions reported